Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
-
Published:2018-12-04
Issue:11
Volume:25
Page:2942-2951
-
ISSN:1359-4184
-
Container-title:Molecular Psychiatry
-
language:en
-
Short-container-title:Mol Psychiatry
Author:
Mukherjee Shubhabrata, , Mez Jesse, Trittschuh Emily H., Saykin Andrew J.ORCID, Gibbons Laura E., Fardo David W.ORCID, Wessels Madeline, Bauman Julianna, Moore Mackenzie, Choi Seo-Eun, Gross Alden L., Rich Joanne, Louden Diana K. N.ORCID, Sanders R. Elizabeth, Grabowski Thomas J., Bird Thomas D., McCurry Susan M., Snitz Beth E., Kamboh M. Ilyas, Lopez Oscar L., De Jager Philip L., Bennett David A., Keene C. Dirk, Larson Eric B., Crane Paul K., , , , ,
Abstract
AbstractCategorizing people with late-onset Alzheimer’s disease into biologically coherent subgroups is important for personalized medicine. We evaluated data from five studies (total n = 4050, of whom 2431 had genome-wide single-nucleotide polymorphism (SNP) data). We assigned people to cognitively defined subgroups on the basis of relative performance in memory, executive functioning, visuospatial functioning, and language at the time of Alzheimer’s disease diagnosis. We compared genotype frequencies for each subgroup to those from cognitively normal elderly controls. We focused on APOE and on SNPs with p < 10−5 and odds ratios more extreme than those previously reported for Alzheimer’s disease (<0.77 or >1.30). There was substantial variation across studies in the proportions of people in each subgroup. In each study, higher proportions of people with isolated substantial relative memory impairment had ≥1 APOE ε4 allele than any other subgroup (overall p = 1.5 × 10−27). Across subgroups, there were 33 novel suggestive loci across the genome with p < 10−5 and an extreme OR compared to controls, of which none had statistical evidence of heterogeneity and 30 had ORs in the same direction across all datasets. These data support the biological coherence of cognitively defined subgroups and nominate novel genetic loci.
Funder
U.S. Department of Health & Human Services | NIH | National Institute on Aging U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology
Reference28 articles.
1. Lam B, Masellis M, Freedman M, Stuss DT, Black SE. Clinical, imaging, and pathological heterogeneity of the Alzheimer’s disease syndrome. Alzheimers Res Ther. 2013;5:1. 2. Cholerton B, Larson EB, Quinn JF, Zabetian CP, Mata IF, Keene CD, et al. Precision medicine: clarity for the complexity of dementia. Am J Pathol. 2016;186:500–6. 3. Girard SL, Rouleau GA. Genome-wide association study in FTD: divide to conquer. Lancet Neurol. 2014;13:643–4. 4. Crane PK, Trittschuh E, Mukherjee S, Saykin AJ, Sanders RE, Larson EB, et al. Incidence of cognitively defined late-onset Alzheimer’s dementia subgroups from a prospective cohort study. Alzheimer’s Dement. 2017;13:1307–16. 5. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34:939–44.
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|